Serialization Clause Samples

The Serialization clause establishes that the written contract represents the complete and exclusive agreement between the parties, superseding all prior negotiations, discussions, or agreements. In practice, this means that any previous understandings, whether oral or written, are not legally binding unless explicitly included in the current contract. This clause ensures that only the terms within the signed document are enforceable, thereby preventing disputes over alleged side agreements or prior statements.
POPULAR SAMPLE Copied 7 times
Serialization. SerializationInfoEnumerator respectively its corresponding Contract Wizard class CW_SERIALIZATION_INFO_ENUMERATOR implement Current. However, they do not return an object of type SYSTEM_OBJECT but of type SERIALIZATION_ENTRY. Normally, this is a legal redeclaration since SERIALIZATION_ENTRY is a subtype of SYSTEM_OBJECT. The problem is that SERIALIZATION_ENTRY is expanded and the compiler states a non conforming signature of the redeclaration. Error code: VDRD(2) Type error: redeclaration has non-conforming signature. What to do: make sure that redeclaration uses signature (number and types of arguments and result) conforming to that of the original. Class: CW_SERIALIZATION_INFO_ENUMERATOR Redefined feature: current_: expanded CW_SERIALIZATION_ENTRY From: CW_SERIALIZATION_INFO_ENUMERATOR Precursor: current_: SYSTEM_OBJECT From: IENUMERATOR
Serialization. All Product delivered by Supplier to Lannett shall meet serialization requirements, as outlined in the Drug Supply Chain Security Act (Title II of the Drug Quality and Security Act) signed into law on November 27, 2013. Requirements include, but are not limited to, the addition of Product identifiers imprinted on each sellable unit, on each homogeneous case and on each pallet intended to be introduced in the United States market. Unique product identifiers will include a national drug code, serial identifier (provided by Lannett), lot number, and expiration date. Serial numbers must be aggregated from item to case and case to pallet.
Serialization. As applicable, Buyer will assign serial numbers and Seller will apply to all products accordingly and record serial numbers on all documentation. Assigned serial numbers shall not be altered or replaced and shall remain properly identified for the entirety of Seller’s liability for the parts. If serialization for any product(s) is in question, for any reason, Seller will notify Buyer immediately to determine a resolution.
Serialization. Contractor’s requests for serial number assignment shall be sent to the following e-mail address: ▇▇▇▇_▇▇▇▇▇▇▇▇▇▇▇.▇▇▇@▇▇▇▇.▇▇▇. 3.0 QUALITY ASSURANCE PROVISIONS
Serialization. All Product delivered by Seller to Lannett shall meet serialization requirements, as outlined in the Drug Supply Chain Security Act (Title II of the Drug Quality and Security Act) signed into law on November 27, 2013 and provide data to support Product traceability as deemed necessary by Lannett. Requirements include, but are not limited to, the addition of unique Product identifiers Global Trade Item Number (“GTIN”), Serial Number (“SN”), Lot of batch number (“LOT”), expiration date (“EXP”) imprinted on each sellable unit, the same unique Product identifiers mentioned above and Quantity (“QTY”) are required on each homogeneous case and Serialized Shipping Container Code, 18-digit (“SSCC18”) on each pallet intended to be introduced in the US market. Serial numbers must be aggregated from unit to case and case to pallet. Reporting of serial number and aggregation data is required to coincide with finished goods shipment and must conform to data exchange format and connectivity specifications supported by TraceLink. 106569863.v1
Serialization. All deliverable Products shall be serialized with regard to the base part number. No two deliverable Products shall have the same serial number. Serial numbers shall remain the same regardless of configuration changes subsequent to acceptance testing. Serial numbers of Products returned and subsequently not resubmitted shall not be re-assigned.
Serialization. The Parties agree and acknowledge that the Falsified Medicines Directive (Directive 2011/62/EU) as amended by Directive 2001/83/EC and the European Commission delegated regulation (EU) 2016/161 of 2 October 2015 (“Delegated Regulation”) supplementing Directive 2001/83/EC of the European Parliament and of the Council by laying down detailed rules for the safety features appearing on the packaging of medicinal products for human use (“Serialization”), are applicable on the sale and distribution of the Product in the Territory. The Parties shall adhere to the legal requirements applicable in the Territory in connection with Serialization. SUPPLIER shall provide DISTRIBUTOR with Product with a unique identifier, tamper-evident seals and all other mandatory master data as further detailed in the Delegated Regulation (e.g. 2D-Data matrix Code, Human readable). DISTRIBUTOR shall register and pay any and all fees, [***] where necessary, associated with the Serialization of the Product at the German Medicines Verification System (securPharm e.V.), the ACS PharmaProtect GmbH, the Informationsstelle für Arzneispezialitäten (IFA) GmbH and any other relevant agency for Serialization in the Territory, [***]. SUPPLIER or its designated onboarding partner with EMVO (the European Medicines Verification Organisation) shall upload the relevant master data relating to DISTRIBUTOR and its Designated Wholesaler.
Serialization. Alvotech shall provide the Product uniquely identified and in compliance with the serialization laws and regulations applicable to the Territory and the country in which the Alvotech Facility that makes a Product is located. Alvotech shall ▇▇▇▇ each Product with a product identifier as required by Applicable Laws. Alvotech and Teva shall cooperate to ensure such information is in proper format and capable of being received through the proper data interchange.
Serialization. The parties shall cooperate with each other to implement serialization of Product using bi-dimensional codes to allow the tracking of Product from the Facility to United Therapeutics’ end-users. MannKind’s costs of such serialization shall be included in COGs.
Serialization. HPS shall include the version, release, and serial number embedded in the object code in each production copy of SyncTrac. HPS will be solely responsible for creation of trial and customer copies of SyncTrac.